Anti-LAT1 antibodies bind extracellular epitopes, induce internalization, and inhibit amino acid uptake, typically leading to antibody-dependent cellular cytotoxicity (ADCC) and tumor suppression in xenograft models. The gene discussed is SLC7A5; the disease is neoplasm.